”the claim will allege that Mesoblast misrepresented the efficacy and potential benefit of treating patients with Remestemcel-L; misrepresented the significance of trial results; did not disclose to the market material information, including the deficiencies in study design and statistics presented.”
Something is not adding up.
In my opinion, this can’t just be left in the market without a response. I think the BoDs need to act like the MSB BoDs for a while (and then when this is over they can go back to whatever it is they were doing before being rudely interrupted).
- Forums
- ASX - By Stock
- AFR reports that the co to be sued for its promotional announcements.
”the claim will allege that Mesoblast misrepresented the...
-
- There are more pages in this discussion • 422 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
96.0¢ |
Change
-0.035(3.52%) |
Mkt cap ! $1.124B |
Open | High | Low | Value | Volume |
$1.00 | $1.01 | 95.0¢ | $1.461M | 1.499M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
15 | 114821 | 95.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
96.0¢ | 36740 | 41 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 114657 | 0.955 |
20 | 323373 | 0.950 |
10 | 111701 | 0.945 |
13 | 173605 | 0.940 |
10 | 535489 | 0.935 |
Price($) | Vol. | No. |
---|---|---|
0.960 | 20506 | 37 |
0.965 | 29812 | 16 |
0.970 | 87438 | 9 |
0.975 | 78467 | 9 |
0.980 | 24276 | 4 |
Last trade - 13.35pm 20/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |